Dispatch Bio Elevates Technical Leadership as It Moves Toward Clinical Stage

According to a recent LinkedIn post from Dispatch Bio, the company has promoted early hire Chris Wiwi to Chief Technical Officer. The post highlights that Wiwi has been leading technical operations across chemistry, manufacturing and controls development, as well as manufacturing activities.

The LinkedIn post suggests that this leadership change is aligned with Dispatch Bio’s transition into clinical development. For investors, the move may indicate maturation of the company’s technical and manufacturing capabilities, which could be important for execution risk, regulatory readiness, and potential scalability of future clinical and commercial programs.